Rosacea and Seborrheic Dermatitis: What the Research Actually Shows

If your face is persistently red and also flakes — around the nose, the eyebrows, the hairline — you have probably been told these are two unrelated things. Treat the redness. Treat the flaking. Two separate problems, two separate solutions.

The research does not support that view. Two independent studies published in 2025, using entirely different patient databases and different statistical methods, both found a substantial link between rosacea and seborrheic dermatitis. One of them goes further, and points toward a shared underlying mechanism that has direct implications for how skincare for this skin should be formulated.

This article looks at what both studies actually found, what they do and do not tell us, and why the second finding matters more than the headline numbers.

Study one: over five million patients, and a two-way relationship

The larger of the two studies was published in Allergy, the journal of the European Academy of Allergy and Clinical Immunology, in October 2025. Led by Sabrina Meng and colleagues at the Perelman School of Medicine, University of Pennsylvania, it examined a cohort of 5,083,689 individuals drawn from a large US administrative claims database covering 2016 to 2022.

Using a multivariable Cox proportional hazards model, the researchers looked at the relationship in both directions — the risk of developing seborrheic dermatitis after a rosacea diagnosis, and the risk of developing rosacea after a seborrheic dermatitis diagnosis. Both were elevated, and by almost exactly the same amount:

• Seborrheic dermatitis after rosacea: hazard ratio 2.84 (95% confidence interval 2.78–2.90).
• Rosacea after seborrheic dermatitis: hazard ratio 2.85 (95% confidence interval 2.79–2.92).

The symmetry is the interesting part. This is not a case of one condition causing the other in a single direction. The relationship runs both ways at almost identical strength, which is what researchers describe as a bidirectional association.

Study two: a different database, the same conclusion

The second study was published in Baylor University Medical Center Proceedings in 2025, led by Ryan S. Koch at Baylor Scott and White Medical Center in Temple, Texas, with colleagues at Texas Tech University Health Sciences Center. It used the TriNetX research database — a completely separate data source from the first study — comparing 106,739 patients with a rosacea diagnosis against a control group of 4,919,403 patients without one.

After propensity score matching, patients with rosacea showed a markedly increased likelihood of also having seborrheic dermatitis: an odds ratio of 6.456 (95% confidence interval 6.155–6.772).

A note on why we are not putting those two numbers side by side as though they are comparable. A hazard ratio and an odds ratio measure different things. A hazard ratio describes the rate at which something develops over time; an odds ratio describes the relative odds of two things appearing together. Presenting 2.84 and 6.456 as competing versions of the same figure would be misleading, and any dermatologist reading it would rightly say so. What matters is not which number is larger, but that two independent research teams, working with different populations and different methods, both found a strong association where conventional skincare assumes none.

The finding that matters more than the numbers

The co-occurrence figures are the headline, but they are not the most useful part of this research for anyone trying to work out what to put on their face.

The Meng study was not designed simply to count overlaps. It was designed to test a hypothesis known as the epithelial barrier theory — the proposition that a range of inflammatory conditions across the skin, airways, gut and eyes may share a common origin in the breakdown of the body's epithelial barriers. Seborrheic dermatitis was examined precisely because it is characterised by barrier dysfunction.

The authors' conclusion is that their results support the epithelial barrier theory as a shared driver, not only at local barriers such as the skin but at other epithelial sites too. In other words: the reason these conditions keep appearing together may be that they are both downstream of the same underlying problem — a compromised barrier.

That is a significant reframing. It suggests that treating redness and flaking as two separate cosmetic targets, each with its own aggressive product, may be addressing symptoms while leaving the shared foundation untouched. If you have ever wondered why your skin seems to trade one problem for another every time you change your routine, this is a plausible part of the answer. We cover the barrier itself in more detail in what the skin barrier is and why it matters so much for reactive skin.

What these studies do not tell us

Being clear about the limits matters as much as reporting the findings.

• Association is not causation. Neither study demonstrates that one condition causes the other. A strong statistical relationship tells us they travel together; it does not establish the mechanism.
• Both are retrospective database studies. They analyse diagnostic codes from existing medical records rather than examining patients directly, which introduces the possibility of coding inconsistencies and diagnostic overlap between two conditions that can look similar on the face.
• Both used US populations. Findings may not translate identically to other countries or to populations with different demographic profiles.
• The barrier theory is a theory. It is well-supported and increasingly influential, but it remains an active area of research rather than settled fact. The Meng authors themselves call for further work on the mechanisms involved.

What this means for how you approach your skin

If you recognise both patterns in your own face, the practical implication is not that you need more products. It is that the order of operations matters. A routine built around calming and supporting the barrier first gives you a stable foundation to judge everything else against — and it avoids the common cycle of applying something for redness that aggravates flaking, then something for flaking that aggravates redness.

In practice, that tends to mean gentle, low-pH cleansing, fragrance-free formulas, and conservative use of actives until skin is settled. Our guide to cleansing without stripping the barrier covers the first step, and our article on the overlap between seborrheic dermatitis and rosacea-prone skin looks at what the two conditions have in common day to day.

It is also worth saying plainly: both of these are medical conditions, and a GP, pharmacist or dermatologist is the right person to diagnose them and advise on treatment. Effective medicated options exist. Cosmetic skincare has a role in daily comfort and in not making things worse — it is not a substitute for medical care.

The reason this research matters to us at Nurest is straightforward. It is the clinical basis for why we formulate around both concerns at once rather than optimising for one and hoping the other tolerates it — you can see how that thinking shapes the Nurest routine we're developing.

If this is the overlap your own skin deals with, join the Nurest early access list — we'll share formulation progress and early access with this list before public release.

Common questions about the rosacea and seborrheic dermatitis link